Q932P5 (Q932P5_9GAMM) Acinetobacter sp A1411
Beta-lactamase UniProtKBAFDB90v4InterProInteractive Modelling
246 aa; Sequence (Fasta) ;
39 identical sequences
It is possible new templates exist for this target since these models were created.
Available Structures
31 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Ligands | ||
|---|---|---|---|---|---|---|
| Crystal structure of metallo-beta-lactamse, IMP-1, in complex with a thiazole-bearing inhibitor | homo-2-mer | 4×ZN; 2×BS0; | ||||
| Assess | ||||||
| Structure-based design of the irreversible inhibitors to metallo--lactamase (IMP-1) | homo-2-mer | 4×ZN; 2×OPS; 1×ACY; | ||||
| Assess | ||||||
| The structure of IMP-1 complexed with the detecting reagent (DansylC4SH) by a fluorescent probe | homo-2-mer | 4×ZN; 2×C4H; | ||||
| Assess | ||||||
| Mutagenesis of zinc ligand residue Cys221 reveals plasticity in the IMP-1 metallo-b-lactamase activ… | monomer | 1×ZN; 2×PO4; 2×SO4; | ||||
| Assess | ||||||
| Mutagenesis of zinc ligand residue Cys221 reveals plasticity in the IMP-1 metallo-b-lactamase activ… | monomer | 1×ZN; 1×FLC; | ||||
| Assess | ||||||
| Crystal structure of metallo-beta-lactamse, IMP-1, complexed with a quinolinone-based inhibitor | monomer | 3×ZN; | ||||
| Assess | ||||||
| Crystal structure of IMP-1 metallo-beta-lactamase in a complex with MCR | monomer | 2×ZN; 1×MCR; 1×EPE; | ||||
| Assess | ||||||
| Crystal structure of IMP-1 metallo-beta-lactamase in complex with NO9 inhibitor | monomer | 2×ZN; 1×NA; 1×NO9; | ||||
| Assess | ||||||
| Crystal Structure Of IMP-1 Metallo-beta-lactamase | monomer | 2×ZN; 1×SO4; 2×EPE; | ||||
| Assess | ||||||
| IMP-1 METALLO BETA-LACTAMASE FROM PSEUDOMONAS AERUGINOSA IN COMPLEX WITH A BIARYL SUCCINIC ACID INH… | monomer | 3×ZN; 1×ACT; 1×BDS; | ||||
| Assess | ||||||
| IMP-1 METALLO BETA-LACTAMASE FROM PSEUDOMONAS AERUGINOSA IN COMPLEX WITH A BIARYL SUCCINIC ACID INH… | monomer | 3×ZN; 1×ACT; 1×BYS; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF IMP-1 METALLO BETA-LACTAMASE FROM PSEUDOMONAS AERUGINOSA | monomer | 2×ZN; 1×ACY; | ||||
| Assess | ||||||
| Crystal structure of the metallo-beta-lactamase IMP-1 with D-captopril | monomer | 2×ZN; 1×MCO; 2×SO4; | ||||
| Assess | ||||||
| Structure of IMP-1 with 2-Mercaptomethyl-thiazolidine L-anti-1b | monomer | 2×ZN; 1×QT2; 1×EDO; | ||||
| Assess | ||||||
| Structure of IMP-1 with 2-Mercaptomethyl-thiazolidine D-syn-1b | monomer | 2×ZN; 1×QST; | ||||
| Assess | ||||||
| Crystal structure of the native, di-zinc metallo-beta-lactamase IMP-1 | monomer | 2×ZN; 1×EDO; 1×ACT; | ||||
| Assess | ||||||
| Crystal structure of metallo-beta-lactamase IMP-1 mutant (D81A) | monomer | 1×ZN; 1×ACY; | ||||
| Assess | ||||||
| Crystal structure of the metallo-beta-lactamase IMP-1 with L-captopril | monomer | 1×X8Z; 3×SO4; 2×ZN; | ||||
| Assess | ||||||
| Crystal structure of IMP-1 MBL in complex with (3-(4-(p-tolyl)-1H-1,2,3-triazol-1-yl)benzyl)phospho… | monomer | 2×ZN; 2×ITK; | ||||
| Assess | ||||||
| Crystal structure of B1 IMP-1 MBL in complex with 2-amino-5-phenethylthiazole-4-carboxylic acid | monomer | 2×ZN; 1×5ZX; 3×ACT; | ||||
| Assess | ||||||
| Crystal structure of B1 IMP-1 MBL in complex with 2-amino-5-phenethylthiazole-4-carboxylic acid | monomer | 2×ZN; 1×5ZX; | ||||
| Assess | ||||||
| Crystal structure of the metallo-beta-lactamase IMP-1 in complex with the bisthiazolidine inhibitor… | monomer | 2×ZN; 1×9BZ; 1×EDO; | ||||
| Assess | ||||||
| Crystal structure of the metallo-beta-lactamase IMP-1 in complex with the bisthiazolidine inhibitor… | monomer | 2×ZN; 2×3R9; | ||||
| Assess | ||||||
| Crystal structure of IMP-1 MBL in complex with 3-(4-benzyl-1H-1,2,3-triazol-1-yl)phthalic acid | monomer | 2×ZN; 1×IT0; | ||||
| Assess | ||||||
| Crystal structure of metallo-beta-lactamase IMP-1 mutant (D120E) in complex with citrate. | monomer | 2×ZN; 1×FLC; 1×AE3; | ||||
| Assess | ||||||
| Crystal structure of metallo-beta-lactamase IMP-1 in complex with a phosphonate-based inhibitor | monomer | 2×ZN; 1×60M; | ||||
| Assess | ||||||
| Crystal structure of metallo-beta-lactamase IMP-1 in complex with citrate. | monomer | 2×ZN; 1×FLC; | ||||
| Assess | ||||||
| Crystal Structure of IMP-1 metallo-beta-lactamase complexed with a 3-aminophtalic acid inhibitor | monomer | 2×ZN; 1×C93; | ||||
| Assess | ||||||
| Crystal structure of metallo-beta-lactamase IMP-1 mutant (D81E) | monomer | 2×ZN; 1×ACY; | ||||
| Assess | ||||||
| Crystal structure of metallo-beta-lactamase IMP-1 | monomer | 2×ZN; | ||||
| Assess | ||||||
| IMP-1 METALLO BETA-LACTAMASE FROM PSEUDOMONAS AERUGINOSA IN COMPLEX WITH A MERCAPTOCARBOXYLATE INHI… | monomer | 1×SO4; 2×ZN; 1×MCI; | ||||
| Assess | ||||||
1 SWISS-MODEL model
| Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 7xhw.1.A | monomer | 0.92 | 2×ZN; | 100.00 | ||
| Assess | ||||||